New evidence suggests that statins generate large survival and health benefits at the population level and shows that the social value of the survival gains are large and go predominantly to consumers, according to a study published in the October issue of Health Affairs.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Social value of statins merits actions to broaden treatment, improve adherence, study finds

Newsletter